BETHPHAGEN INC has a total of 20 patent applications. It increased the IP activity by 1000.0%. Its first patent ever was published in 2016. It filed its patents most often in Republic of Korea, United States and China. Its main competitors in its focus markets pharmaceuticals, biotechnology and agriculture are JING ZHANG, NIPPON INST FOR BIOLOG SCIENCE and HOMOLOGY MEDICINES INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Republic of Korea | 6 | |
#2 | United States | 5 | |
#3 | China | 3 | |
#4 | EPO (European Patent Office) | 3 | |
#5 | WIPO (World Intellectual Property Organization) | 3 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Agriculture | |
#4 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Microorganisms | |
#4 | Animal care | |
#5 | Peptides | |
#6 | Enzymes | |
#7 | Special foods | |
#8 | Foods |
# | Name | Total Patents |
---|---|---|
#1 | Park Woo Jin | 17 |
#2 | Kwak Tae Hwan | 11 |
#3 | Lee Min-Ah | 8 |
#4 | Jeong Dongtak | 6 |
#5 | Lee Min Ah | 5 |
#6 | Jeong Dong Tak | 5 |
#7 | Oh Jae Gyun | 1 |
#8 | Park Woo-Jin | 1 |
#9 | Hajjar Roger J | 1 |
#10 | Jang Seung Pil | 1 |
Publication | Filing date | Title |
---|---|---|
CN111465697A | Pharmaceutical composition for preventing or treating heart failure | |
KR20190038425A | Pharmaceutical composition for preventing or treating cardiac arrhythmias | |
WO2017082701A1 | Pharmaceutical composition for treatment of cardiac fibrosis |